BI Asset Management Fondsmaeglerselskab A S Has $32.17 Million Stock Holdings in Intuitive Surgical, Inc. $ISRG

BI Asset Management Fondsmaeglerselskab A S increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 37.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 56,803 shares of the medical equipment provider’s stock after acquiring an additional 15,446 shares during the quarter. BI Asset Management Fondsmaeglerselskab A S’s holdings in Intuitive Surgical were worth $32,171,000 at the end of the most recent quarter.

Several other large investors have also made changes to their positions in ISRG. Brighton Jones LLC lifted its stake in shares of Intuitive Surgical by 24.9% during the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock valued at $1,916,000 after acquiring an additional 731 shares during the period. Sivia Capital Partners LLC increased its holdings in Intuitive Surgical by 3.8% in the second quarter. Sivia Capital Partners LLC now owns 928 shares of the medical equipment provider’s stock valued at $504,000 after purchasing an additional 34 shares during the last quarter. Schnieders Capital Management LLC. increased its holdings in Intuitive Surgical by 38.0% in the second quarter. Schnieders Capital Management LLC. now owns 973 shares of the medical equipment provider’s stock valued at $529,000 after purchasing an additional 268 shares during the last quarter. Osterweis Capital Management Inc. bought a new stake in Intuitive Surgical in the second quarter valued at about $200,000. Finally, Main Street Financial Solutions LLC increased its holdings in Intuitive Surgical by 92.4% in the second quarter. Main Street Financial Solutions LLC now owns 2,929 shares of the medical equipment provider’s stock valued at $1,592,000 after purchasing an additional 1,407 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Activity

In related news, Director Amy L. Ladd sold 500 shares of the stock in a transaction that occurred on Tuesday, April 28th. The stock was sold at an average price of $473.46, for a total transaction of $236,730.00. Following the completion of the transaction, the director directly owned 239 shares of the company’s stock, valued at approximately $113,156.94. This represents a 67.66% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Iman Jeddi sold 5,625 shares of the stock in a transaction that occurred on Monday, June 1st. The shares were sold at an average price of $420.55, for a total value of $2,365,593.75. Following the transaction, the senior vice president directly owned 6,463 shares of the company’s stock, valued at $2,718,014.65. This trade represents a 46.53% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 7,448 shares of company stock valued at $3,224,404. Corporate insiders own 0.60% of the company’s stock.

Analyst Ratings Changes

A number of research firms recently commented on ISRG. UBS Group dropped their price objective on Intuitive Surgical from $570.00 to $550.00 and set a “neutral” rating for the company in a report on Tuesday, March 17th. Weiss Ratings reiterated a “hold (c)” rating on shares of Intuitive Surgical in a report on Tuesday, May 19th. Citigroup upgraded Intuitive Surgical from a “neutral” rating to a “buy” rating and set a $590.00 price objective for the company in a report on Wednesday, March 11th. Barclays set a $651.00 price objective on Intuitive Surgical and gave the company an “overweight” rating in a report on Thursday, April 23rd. Finally, Mizuho set a $525.00 price target on Intuitive Surgical and gave the stock a “neutral” rating in a report on Monday, April 13th. Nineteen investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Intuitive Surgical presently has an average rating of “Moderate Buy” and an average target price of $573.63.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $422.06 on Friday. The company has a market cap of $149.48 billion, a PE ratio of 51.16, a PEG ratio of 3.34 and a beta of 1.46. Intuitive Surgical, Inc. has a 52-week low of $396.68 and a 52-week high of $603.88. The stock has a 50-day simple moving average of $447.24 and a 200 day simple moving average of $501.02.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.08 by $0.42. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.The business had revenue of $2.77 billion during the quarter, compared to the consensus estimate of $2.62 billion. During the same period last year, the company earned $1.81 earnings per share. Intuitive Surgical’s quarterly revenue was up 23.0% on a year-over-year basis. On average, research analysts predict that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.